Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 18 of 18 entries
View as:

Immunogenicity, Safety, and Tolerability of a Plant-Derived Quadrivalent VLP Influenza Vaccine in Elderly Adults

Phase: N/A Priority: Normal
NCT ID: NCT02831751 Org: User:
Start: 04/30/16 End: 01/31/17 Due: 01/31/18

Lot-to-lot Consistency of a Plant-Derived Quadrivalent Virus-Like Particles Influenza Vaccine in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT03321968 Org: User:
Start: 09/29/17 End: 12/01/17 Due: 12/01/18

Adjuvanted Seasonal Recombinant Quadrivalent Virus-Like Particles (QVLP) Influenza Vaccine in Adults 65 Years of Age and Older

Phase: N/A Priority: Normal
NCT ID: NCT04622592 Org: User:
Start: 11/02/20 End: 04/26/22 Due: 04/26/23

Efficacy of a Plant-derived Quadrivalent Virus-like Particle (VLP) Vaccine in the Elderly

Phase: N/A Priority: Normal
NCT ID: NCT03739112 Org: User:
Start: 09/18/18 End: 07/16/19 Due: 07/16/20

Efficacy, Safety, and Immunogenicity of a Plant-Derived Quadrivalent Virus-Like Particles (VLPs) Influenza Vaccine in Adults

Phase: N/A Priority: Normal
NCT ID: NCT03301051 Org: User:
Start: 08/31/17 End: 05/09/18 Due: 05/09/19

Phase 3 Study to Evaluate the Lot Consistency of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT05040789 Org: User:
Start: 11/22/21 End: 05/31/22 Due: 05/31/23

Immunogenicity, Safety and Tolerability of a Plant-Derived Seasonal VLP Quadrivalent Influenza Vaccine in the Elderly Population

Phase: N/A Priority: Normal
NCT ID: NCT02236052 Org: User:
Start: 07/16/14 End: 06/17/15 Due: 06/17/16

Safety, Tolerability and Immunogenicity of a Plant-made Seasonal Quadrivalent VLP Influenza Vaccine in Adults

Phase: N/A Priority: Normal
NCT ID: NCT01991587 Org: User:
Start: 10/08/13 End: 06/30/14 Due: 06/30/15

Immunogenicity, Safety, Tolerability of a Plant-made H5 Virus-like-particle (VLP) Influenza Vaccine.

Phase: N/A Priority: Normal
NCT ID: NCT01991561 Org: User:
Start: 06/30/13 End: 11/30/14 Due: 11/30/15

Immunogenicity, Safety and Tolerability of a Plant-Derived Seasonal Virus-Like-Particle Quadrivalent Influenza Vaccine in Adults

Phase: N/A Priority: Normal
NCT ID: NCT02233816 Org: User:
Start: 07/28/14 End: 06/22/15 Due: 06/22/16

Safety, Tolerability and Immunogenicinity of a Coronavirus-Like Particle COVID-19 Vaccine in Adults Aged 18-55 Years.

Phase: N/A Priority: Normal
NCT ID: NCT04450004 Org: User:
Start: 07/10/20 End: 08/30/21 Due: 08/30/22

Safety, Tolerability and Immunogenicity of a Plant-Made H1 VLP Influenza Vaccine in Adults

Phase: N/A Priority: Normal
NCT ID: NCT01302990 Org: User:
Start: 02/28/11 End: 11/30/11 Due: 11/30/12

Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults

Phase: N/A Priority: Normal
NCT ID: NCT04636697 Org: User:
Start: 11/19/20 End: 04/30/22 Due: 04/30/23

Immunogenicity of a Quadrivalent Virus-Like Particles (VLP) Influenza Vaccine in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT02768805 Org: User:
Start: 03/02/16 End: 11/26/16 Due: 11/26/17

Safety Study of a Plant-based H5 Virus-Like Particles (VLP) Vaccine in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT00984945 Org: User:
Start: 09/30/09 End: 07/31/10 Due: 07/31/11

Immunogenicity, Safety, Tolerability of a Plant-Made H5 VLP Influenza Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT01244867 Org: User:
Start: 11/30/10 End: 09/30/11 Due: 09/30/12

Safety, Tolerability and Immunogenicity of a Plant-made H7 Virus-like Particle (VLP) Influenza Vaccine in Adults.

Phase: N/A Priority: Normal
NCT ID: NCT02022163 Org: User:
Start: 12/31/13 End: 12/31/14 Due: 12/31/15

Safety Immunogenicity Study of MT-2766 in Japanese Adults（COVID-19）

Phase: N/A Priority: Normal
NCT ID: NCT05065619 Org: User:
Start: 10/02/21 End: 01/29/23 Due: 01/29/24